Roth Capital Analysts Increase Earnings Estimates for FBIO
Fortress Biotech, Inc. (NASDAQ:FBIO – Free Report) – Equities researchers at Roth Capital boosted their Q2 2025 earnings estimates for shares of Fortress Biotech in a research report issued on Tuesday, May 20th. Roth Capital analyst J. Wittes now forecasts that the biopharmaceutical company will earn ($0.31) per share for the quarter, up from their […]
Fortress Biotech, Inc. (NASDAQ:FBIO – Free Report) – Equities researchers at Roth Capital boosted their Q2 2025 earnings estimates for shares of Fortress Biotech in a research report issued on Tuesday, May 20th. Roth Capital analyst J. Wittes now forecasts that the biopharmaceutical company will earn ($0.31) per share for the quarter, up from their […]
